How Epigenetics Functions

In this article11 sections · 14 min read

Key Definitions The Molecular Machinery: How Cells Turn Genes On and Off X-Inactivation: A Textbook Example With a Real Mechanism Genomic Imprinting: When Parental Origin Matters Environmental Influence on Gene Expression: What the Evidence Actually Supports Transgenerational Inheritance: What Is Solid and What Is Overstated Epigenetics in Medicine: Cancer and Beyond What Epigenetics Does Not Mean Related Articles Sources & Further Reading Further Reading

Cells with identical DNA can do different jobs because epigenetic mechanisms regulate which genes are read without changing the sequence itself. How epigenetics functions involves DNA methylation, histone modifications, chromatin structure, and non-coding RNA. These processes guide development and respond to some environmental inputs, but claims about sweeping inherited effects in humans exceed the strongest available evidence.

Conrad Waddington, a British developmental biologist, coined the word "epigenetics" in 1942 to describe a puzzle that had nothing to do with DNA sequence at all: how a single fertilized egg, carrying one genome, gives rise to hundreds of different cell types, each reading the same genetic instructions in a completely different way.

A liver cell and a neuron carry identical DNA, yet one metabolizes toxins and the other fires action potentials. Waddington imagined development as a ball rolling down a landscape of branching valleys, a metaphor for how a cell's fate becomes progressively locked in even though its underlying genetic material never changes.^[1]

He did not yet know the molecular mechanism. That would take another half century of biochemistry to work out, and the answer turned out to be broader and more consequential than Waddington could have anticipated: the same molecular switches that guide a fertilized egg into a liver cell or a neuron also respond, throughout life, to diet, stress, toxin exposure, and other environmental inputs, turning genes up or down without altering the underlying DNA sequence itself.

That combination, a real and well-documented biological mechanism wrapped in decades of popular exaggeration about how much control it hands us over our own genes, makes epigenetics one of the most widely misunderstood ideas in modern biology.

Key Definitions

Epigenetics: the study of heritable changes in gene expression that occur without changes to the underlying DNA sequence; from the Greek prefix "epi," meaning "on top of" or "in addition to," referring to a layer of regulation on top of the genome itself.

Gene expression: the process by which information in a gene is used to produce a functional product, typically a protein; a gene that is "expressed" in a given cell is actively being read and used, while a "silenced" gene is present but inactive.

DNA methylation: the addition of a methyl group (CH3) to a DNA base, almost always cytosine, most commonly at sites where cytosine is followed by guanine (CpG sites); methylation at gene-regulatory regions typically suppresses gene expression.

Histones: the proteins around which DNA is wound to form chromatin; chemical modifications to histone tails (acetylation, methylation, phosphorylation, and others) change how tightly DNA is packaged and how accessible it is to the cellular machinery that reads genes.

Chromatin: the combined structure of DNA and its associated histone proteins; chromatin can be loosely packed ("euchromatin," generally more active) or tightly packed ("heterochromatin," generally silenced).

Histone acetylation: the addition of an acetyl group to histone proteins, which loosens chromatin structure and is generally associated with increased gene expression; removed by enzymes called histone deacetylases (HDACs).

Non-coding RNA: RNA molecules that are not translated into protein but instead regulate gene expression directly, including microRNAs, which can bind messenger RNA and block or degrade it, and long non-coding RNAs, which can recruit chromatin-modifying complexes to specific genomic locations.

X-inactivation: the epigenetic silencing of one of the two X chromosomes in every cell of a female mammal, ensuring that females, who have two X chromosomes, and males, who have one, produce roughly equal amounts of X-linked gene products; a classic, well-established example of epigenetic regulation.

Genomic imprinting: a form of epigenetic regulation in which a gene's expression depends on whether it was inherited from the mother or the father, with one parental copy chemically marked for silencing regardless of its own sequence.

Transgenerational epigenetic inheritance: the passing of epigenetic marks, rather than DNA sequence changes, from one generation to the next; well documented in plants and in some laboratory studies of worms and rodents, but far more contested and difficult to establish in humans.

The Molecular Machinery: How Cells Turn Genes On and Off

Every cell in the human body, with a small number of exceptions like mature red blood cells, carries a complete copy of the genome, roughly three billion DNA base pairs encoding around twenty thousand protein-coding genes.

A cell does not use most of that information at any given time. A skin cell does not need the genes for making insulin active, and a pancreatic beta cell does not need the genes for making keratin active. Epigenetic mechanisms are the primary way cells enforce that division of labor.

DNA methylation is the best studied of these mechanisms. When methyl groups are added to cytosine bases in the regulatory region of a gene, known as its promoter, the modification typically recruits proteins that compact the surrounding chromatin and physically block the cellular machinery that would otherwise read the gene.

The pattern of methylation across the genome is not random. It is established during embryonic development in a coordinated process, largely erased and reset between generations, and then re-established in a way that matches each cell's ultimate identity, an oocyte's methylation pattern looks nothing like a mature neuron's, even though both descend from the same fertilized egg.

Histone modification works alongside methylation through a different physical mechanism. DNA does not float freely in the nucleus; it is wound around spool-like clusters of histone proteins, and the tightness of that winding determines whether the genetic machinery can access a given stretch of DNA at all.

Enzymes add or remove small chemical groups, acetyl groups, methyl groups, phosphate groups, to the protruding tails of histone proteins, and each combination of modifications changes how tightly the DNA is wound. Loosely wound chromatin is generally accessible and associated with active genes; tightly wound chromatin is generally inaccessible and associated with silenced genes.

Researchers sometimes describe the overall pattern of histone modifications across the genome as a "histone code," since particular combinations of modifications are consistently associated with particular functional states, though the metaphor should not be taken to imply a system as rigid or universally interpretable as the genetic code itself.

Non-coding RNA adds a third layer. Many regions of the genome are transcribed into RNA molecules that are never translated into protein.

Some of these, called microRNAs, are short sequences that bind to messenger RNA and either block its translation or mark it for degradation, providing a fast, reversible way to dial gene expression up or down. Others, called long non-coding RNAs, can physically recruit the enzymes that add or remove methylation and histone marks to specific locations in the genome, effectively serving as an address label that tells the chromatin-modifying machinery where to act.

X-Inactivation: A Textbook Example With a Real Mechanism

The clearest, most thoroughly characterized example of epigenetic regulation in mammals is X-chromosome inactivation, first proposed by geneticist Mary Lyon in 1961 based on patterns of coat-color mosaicism she observed in mice.^[2]

Female mammals carry two X chromosomes, while males carry one X and one Y. Because the X chromosome carries hundreds of genes unrelated to sex determination, a female with two fully active X chromosomes would produce roughly twice as much of those gene products as a male, a mismatch, called a dosage imbalance, that would disrupt normal cell function.

Early in female embryonic development, each cell independently and essentially randomly silences one of its two X chromosomes, a process driven by a long non-coding RNA called Xist, which coats the chromosome destined for silencing and recruits the chromatin-modifying machinery that compacts it into inactive heterochromatin.

Once a cell has inactivated a particular X chromosome, that same X remains inactive in all of that cell's descendants for the rest of the organism's life, a stable, heritable epigenetic decision made at the level of individual cells rather than the whole organism.

The result is that every female mammal is a genetic mosaic: roughly half her cells express genes from the X chromosome inherited from her mother, and roughly half express genes from the X inherited from her father.

Calico cats are the most visually striking illustration of this process. The gene for orange versus black fur color sits on the X chromosome, so a female cat that inherited one X carrying the orange variant and one X carrying the black variant develops patches of each color, corresponding to which X chromosome happened to be silenced in the skin cells that gave rise to each patch.

Genomic Imprinting: When Parental Origin Matters

Under normal Mendelian inheritance, it should not matter which parent a gene came from, a gene inherited from the mother and the identical gene inherited from the father should function identically. Genomic imprinting is the well-documented exception.

For a small number of genes, roughly one hundred have been confirmed in humans, one parental copy is epigenetically marked, typically through DNA methylation established during the formation of sperm or egg cells, in a way that silences that copy regardless of its own DNA sequence.

The clinical importance of imprinting became clear through two related but distinct genetic conditions affecting the same region of chromosome 15. Prader-Willi syndrome, characterized by short stature, intellectual disability, and an insatiable appetite that can lead to severe obesity, occurs when the paternal copy of this chromosomal region is missing or non-functional, leaving only the (normally silenced) maternal copy.

Angelman syndrome, characterized by severe intellectual disability, seizures, and a distinctive happy demeanor, occurs when the maternal copy of a nearby but distinct gene in the same region is missing or non-functional, leaving only the (normally silenced) paternal copy.

The same underlying chromosomal region, disrupted in almost the same location, produces two clinically distinct syndromes depending entirely on which parent's copy was affected, a direct clinical demonstration that epigenetic marks, not just DNA sequence, determine how a gene functions.

Environmental Influence on Gene Expression: What the Evidence Actually Supports

The idea that epigenetics is popularly associated with, that experience and environment can alter which genes are turned on or off, has real experimental support, though the strength of that support varies considerably by claim.

The best-established line of evidence comes from studies of early-life stress in rodents.

Research by Michael Meaney and colleagues at McGill University, published across the early 2000s, found that rat pups receiving high levels of maternal grooming and licking in the first days of life showed different methylation patterns at a gene controlling stress-hormone receptor production in the brain than pups receiving low levels of maternal care, and that this difference persisted into adulthood and was associated with measurably different stress responses.

Cross-fostering experiments, in which pups born to low-licking mothers were raised by high-licking mothers and vice versa, showed that the epigenetic pattern followed the rearing environment rather than genetic parentage, direct evidence that the environmental experience itself, not an inherited genetic difference, was driving the epigenetic change.^[3]

Human research in this area is necessarily observational rather than experimental, since researchers cannot randomly assign children to different caregiving conditions, which limits how strongly causal claims can be made, but studies of early childhood adversity have found associated differences in methylation patterns at comparable stress-related genes, a pattern broadly consistent with the animal research even though the human evidence is correlational.

Studies of identical twins have provided another important line of evidence.^[4]

Because identical twins share essentially the same DNA sequence, differences between them in disease risk or gene expression cannot be explained by genetics alone, and researchers have documented that identical twins' epigenetic marks, similar in early life, diverge progressively as they age and accumulate different life experiences, providing a natural demonstration that environment shapes the epigenome over time independent of DNA sequence.

Diet and metabolism represent a more contested area. Studies of the Dutch Hunger Winter of 1944 to 1945, during which a severe wartime famine affected a defined population for a defined period, found that people who were in early gestation during the famine showed altered methylation patterns at a gene involved in growth regulation decades later, and had higher rates of obesity and cardiovascular disease in adulthood than siblings not exposed to the famine in utero.

This remains one of the more carefully documented examples of an environmental exposure being associated with both a specific, measurable epigenetic change and a specific, measurable health outcome, though as with all human observational research, it cannot fully rule out other contributing factors.

Transgenerational Inheritance: What Is Solid and What Is Overstated

The most scientifically contested and most frequently overstated claim in popular coverage of epigenetics is that acquired epigenetic changes, marks picked up during an individual's lifetime in response to diet, stress, or toxin exposure, can be passed down to children and grandchildren who never experienced the original exposure themselves.

In plants and in some simple laboratory organisms, particularly the roundworm Caenorhabditis elegans, this kind of transgenerational epigenetic inheritance is well documented and mechanistically understood, in part because these organisms lack the thorough epigenetic "reset" that occurs in mammalian reproduction.

In mammals, the picture is far more complicated. During the formation of sperm and egg cells, and again shortly after fertilization, the mammalian genome undergoes extensive demethylation and remethylation, a reset process that erases most, though evidence suggests probably not all, acquired epigenetic marks between generations.

A small number of rodent studies have reported that specific epigenetic marks associated with paternal diet, stress, or toxin exposure persist into offspring and even grandoffspring generations, escaping the normal reset process at particular genomic locations.

These findings are real and have been published in leading journals, but they typically involve small numbers of animals, specific and sometimes difficult-to-replicate experimental conditions, and mechanisms that remain incompletely understood.

Human transgenerational epigenetic inheritance is considerably harder to establish than the rodent findings, since human generations are decades apart, confounding factors are difficult to control for, and directly observing an epigenetic mark's persistence across three or more human generations requires research designs that are logistically very difficult to execute.

Some human studies, including a smaller and more contested body of literature examining descendants of Dutch Hunger Winter survivors and descendants of Holocaust survivors, have reported associations between ancestral exposure and offspring health or stress-hormone regulation.

But these studies have faced substantial methodological criticism regarding sample size, the difficulty of ruling out cultural or behavioral transmission as an alternative explanation, and the general difficulty of establishing a clear causal epigenetic mechanism in humans.

The honest summary, and one that responsible science communicators are careful to make, is that transgenerational epigenetic inheritance is a real, mechanistically demonstrated phenomenon in some non-human organisms and a plausible but far less securely established phenomenon in humans, not the settled, generally applicable mechanism that much popular coverage implies.

Epigenetics in Medicine: Cancer and Beyond

Cancer is the disease area where epigenetic mechanisms have moved furthest from basic research into actual clinical practice.

Tumor cells frequently show abnormal patterns of DNA methylation, commonly the silencing of tumor-suppressor genes that would otherwise restrain uncontrolled cell division, alongside broader disruption of normal histone modification patterns.

Because these epigenetic changes, unlike DNA mutations, are in principle reversible, they represent a distinct category of drug target from conventional cancer genetics.

Several drug classes that block the enzymes responsible for abnormal DNA methylation or histone modification, including DNA methyltransferase inhibitors and histone deacetylase inhibitors, have received regulatory approval for specific cancers, particularly certain blood cancers such as myelodysplastic syndrome and cutaneous T-cell lymphoma.

Beyond cancer, researchers are investigating epigenetic mechanisms in a range of conditions including some psychiatric disorders, autoimmune diseases, and cardiovascular disease, though these applications remain considerably earlier-stage than the cancer-focused epigenetic drugs already in clinical use.

Epigenetic clocks, statistical models that estimate biological age from patterns of DNA methylation across dozens or hundreds of genomic sites, represent a newer and still-developing research area.

Work by researchers including Steve Horvath has shown that these methylation-based age estimates correlate with chronological age and, in some studies, predict mortality risk and age-related disease better than chronological age alone, though epigenetic clocks remain a research tool rather than an established, individually predictive clinical test.^[5]

What Epigenetics Does Not Mean

Given how frequently epigenetics is invoked in popular health and self-improvement writing, it is worth being explicit about what the evidence does not support.

Epigenetics does not mean that lifestyle choices can rewrite a person's DNA sequence, cure a genetic disease outright, or grant the kind of complete, deliberate control over gene expression that some popular accounts imply. The underlying DNA sequence is not changed by diet, meditation, or willpower; what changes is which genes, already present in the sequence, get turned up or down.

Most documented epigenetic effects are modest in size, specific to particular genes and tissues, and difficult to demonstrate causally in humans given the ethical and practical limits on human experimentation.

Extraordinary claims that a specific food, supplement, or practice will "turn on" a specific beneficial gene or "turn off" a specific disease gene should be treated with particular skepticism unless backed by the same kind of randomized, replicated evidence expected in any other area of medicine.

The realistic picture supported by the evidence is more modest than the popular one, and also more interesting: cells possess an elaborate, evolutionarily ancient system for reading the same genome differently depending on context, a system shaped by development, and, to a real but more limited extent than commonly claimed, by the environment and experiences of an organism's life.

Sources & Further Reading

Waddington, C. H. (1942). The epigenotype. Endeavour, 1, 18-20.
Lyon, M. F. (1961). Gene action in the X-chromosome of the mouse (Mus musculus L.). Nature, 190(4773), 372-373. DOI: 10.1038/190372a0
Weaver, I. C. G., Cervoni, N., Champagne, F. A., D'Alessio, A. C., Sharma, S., Seckl, J. R., Dymov, S., Szyf, M., & Meaney, M. J. (2004). Epigenetic programming by maternal behavior. Nature Neuroscience, 7(8), 847-854. DOI: 10.1038/nn1276
Fraga, M. F., Ballestar, E., Paz, M. F., et al. (2005). Epigenetic differences arise during the lifetime of monozygotic twins. Proceedings of the National Academy of Sciences, 102(30), 10604-10609. DOI: 10.1073/pnas.0500398102
Horvath, S. (2013). DNA methylation age of human tissues and cell types. Genome Biology, 14(10), R115. DOI: 10.1186/gb-2013-14-10-r115

Frequently asked questions

Genetics is the study of DNA sequences, the order of the four chemical bases (adenine, thymine, cytosine, guanine) that encode the instructions for building proteins. Every cell in your body contains the same DNA sequence: the same genetic instructions that were present in the fertilized egg you developed from.

Epigenetics is the study of the system that determines which parts of those instructions are actually read in any given cell, at any given time, in response to any given conditions, without changing the underlying DNA sequence. The word ‘epigenetics’ literally means ‘above genetics,’ reflecting that epigenetic regulation operates at a level above the DNA sequence itself.

Conrad Waddington, who coined the term in 1942, used it in a broader developmental biology sense: the study of how genes interact with the environment to produce the phenotype. In contemporary molecular biology, epigenetics refers specifically to heritable changes in gene expression that do not involve changes to the DNA sequence.

The key word is ‘heritable’: epigenetic marks can be passed from a cell to its daughter cells through cell division, maintaining patterns of gene expression across many rounds of replication. The practical significance of this is profound: it explains how a liver cell and a neuron, despite containing identical DNA, are radically different in structure and function. They have different epigenetic marks that determine which genes are expressed in each cell type.

These marks were established during development and are stably maintained throughout the organism’s life. Epigenetics is also the mechanism by which environmental experiences, stress, nutrition, toxin exposure, can alter gene expression patterns, sometimes in long-lasting ways.

DNA methylation is the addition of a methyl group (CH3) to the cytosine base in DNA, almost always at specific sites called CpG dinucleotides (where cytosine is followed by guanine in the DNA sequence). Approximately 80 percent of CpG sites in the human genome are methylated under normal conditions.

Promoter regions, the DNA sequences that control whether a gene is transcribed into RNA, are often associated with clusters of CpG sites called ‘CpG islands.’ When these islands are methylated, the gene is generally silenced: the methylation physically and biochemically blocks the transcriptional machinery from reading the gene, and also recruits proteins that further compact the DNA into a structure that is inaccessible to transcription factors.

Conversely, unmethylated promoter CpG islands are associated with transcriptionally active genes. DNA methylation is relatively stable, it persists through cell division, and can be detected using a technique called bisulfite sequencing. Histone modification is a complementary layer of epigenetic regulation. DNA in the cell nucleus is not free; it is wrapped around proteins called histones, forming a compact structure called chromatin.

The tail regions of histones, segments that protrude from the nucleosome, are subject to many types of chemical modification: acetylation, methylation, phosphorylation, ubiquitination, and others. Histone acetylation (the addition of acetyl groups) generally loosens the chromatin structure, making DNA more accessible to transcriptional machinery and therefore increasing gene expression.

Histone methylation has variable effects depending on which amino acid is methylated and whether one, two, or three methyl groups are added. The combinatorial ‘histone code’ created by the pattern of modifications across many sites is read by regulatory proteins that either activate or repress transcription. Together, DNA methylation and histone modifications work as coordinated, mutually reinforcing layers of gene regulation.

Yes, and this is one of the most active and consequential areas of current epigenetics research. The clearest evidence comes from studies in model organisms, where experimental conditions can be controlled in ways impossible in humans.

Michael Meaney and Moshe Szyf’s seminal research at McGill University, published in a landmark 2004 Nature Neuroscience paper with Ian Weaver and colleagues, showed that the quality of maternal care in rats, specifically, how much the mother licked and groomed her pups, produced lasting differences in the epigenetic regulation of the glucocorticoid receptor gene in the hippocampus of offspring.

High-licking mothers produced offspring with lower methylation of the glucocorticoid receptor promoter, more receptor expression, and lower stress reactivity throughout life. Low-licking mothers produced the opposite pattern. Crucially, this epigenetic difference was not fixed at birth, it was established in early postnatal life through experience, and it could be pharmacologically reversed in adult animals using a histone deacetylase inhibitor.

In humans, the evidence is more complex and the ethical constraints on experimental study are obviously prohibitive. Rachel Yehuda’s research on Holocaust survivors and their children found altered cortisol levels and methylation patterns on stress-related genes (particularly FKBP5, which regulates glucocorticoid receptor sensitivity) in both survivors and their offspring, suggesting that the biological signature of extreme trauma may transmit to the next generation.

These findings have attracted significant attention but also scrutiny: sample sizes are small, replication in independent cohorts is limited, and the causal mechanisms are not fully established. Other research has shown epigenetic effects of early childhood adversity, socioeconomic deprivation, and chronic psychological stress on methylation patterns at relevant gene loci.

The evidence collectively supports the conclusion that stress and trauma can alter gene regulation in lasting ways, though the full extent and mechanisms of these effects remain under investigation.

Steve Horvath’s 2013 Genome Biology paper introduced the concept of the ‘epigenetic clock’: a mathematical model that uses DNA methylation patterns at specific CpG sites to predict chronological age with remarkable accuracy. Horvath analyzed methylation data from over 8,000 samples representing 51 different tissue types and cell types, and identified a set of 353 CpG sites whose methylation levels changed in a consistent, predictable pattern across the human lifespan.

The model using these sites could predict chronological age from a DNA sample with a median absolute error of approximately 3.6 years, better than any other biological marker known at the time. Subsequent research developed additional epigenetic clocks, the Hannum clock, the PhenoAge clock, GrimAge, that not only predict chronological age but also independently predict mortality risk, disease onset, and other health outcomes.

These second-generation clocks measure what has been called ‘biological age’ or ‘epigenetic age’: a measure of how rapidly the epigenome is aging, which can diverge from chronological age. Individuals whose epigenetic age is older than their chronological age (positive ‘epigenetic age acceleration’) show higher risks of a range of age-related diseases and earlier mortality, even after controlling for chronological age and other known risk factors.

The epigenetic clock accelerates in response to chronic stress, adversity, trauma, smoking, and obesity, and appears to decelerate in response to exercise, healthy diet, and other health-promoting behaviors. The biological significance of the clock, whether it is a driver of aging or merely a marker of underlying processes, is still being determined.

But its predictive validity for health outcomes makes it one of the most powerful tools yet developed for measuring biological aging.

This is the most contested question in contemporary epigenetics, and the answer depends critically on the organism, the type of epigenetic mark, and the degree of evidence required. In plants, transgenerational epigenetic inheritance, the transmission of epigenetic marks from parents to offspring, is well established and plays an important role in adaptation.

In animals, including mammals, the situation is more complicated because of a process called epigenetic reprogramming: when germ cells (sperm and eggs) form and when the embryo develops after fertilization, most epigenetic marks are systematically erased and reset. This reprogramming is the main reason that most environmentally acquired epigenetic changes do not pass to offspring. However, there are documented exceptions.

Some specific genomic regions, particularly imprinted genes and certain retrotransposons, escape reprogramming and can transmit epigenetic marks across generations.

Lars Olov Bygren’s work on the Overkalix cohort in Sweden showed associations between paternal grandparents’ food availability in a specific developmental window and descendants’ mortality risk, a provocative finding suggesting that nutritional experiences might transmit across generations through some biological mechanism, though whether epigenetics is the actual channel is debated.

Brian Dias and Kerry Bhattacharya’s 2014 Nature Neuroscience paper showed that mice conditioned to fear a specific odor transmitted enhanced sensitivity to that odor to their offspring and grandoffspring, apparently through methylation changes at the relevant olfactory receptor gene in sperm. This finding attracted enormous attention but has not been fully replicated in all its claimed details.

Rachel Yehuda’s Holocaust research suggests inter-generational transmission in humans, but the sample sizes and methodological complexity make firm conclusions difficult. The current scientific consensus is that while some specific transgenerational epigenetic transmission occurs in mammals, it is not the general rule, and the evidence for robust human transgenerational epigenetic inheritance of acquired characteristics remains limited.

No, though the confusion is understandable and the distinction matters for both scientific accuracy and avoiding overclaiming. Jean-Baptiste Lamarck’s early nineteenth-century evolutionary theory proposed that acquired characteristics, traits an organism develops in response to its environment during its lifetime, can be directly inherited by offspring.

The giraffe’s long neck in Lamarck’s theory elongated through use during the animal’s lifetime, and this acquired elongation was then passed to offspring. This theory was displaced by Darwinian natural selection, which holds that heritable variation arises from random mutation rather than from environmentally directed modification, and that selection acts on this pre-existing heritable variation.

The reason epigenetics is not Lamarckian inheritance, in the full sense, is epigenetic reprogramming. When germ cells form in mammals, most epigenetic marks accumulated during the parent’s lifetime are systematically erased. A parent who develops a specific methylation pattern in liver cells in response to a high-fat diet does not generally transmit those liver-cell methylation patterns to offspring. The gametic epigenome is substantially reset with each generation.

The exceptions to this rule, cases where some epigenetic marks escape reprogramming and appear in offspring, do have a superficial resemblance to Lamarckian inheritance in that they involve environmentally influenced changes that persist across generations.

But they differ in important ways: they affect a small fraction of the epigenome, not all acquired characteristics; the mechanism is not a general inheritance of experience but the escape of specific marks from reprogramming; and the evidence for robust, lasting transmission across multiple generations in mammals is limited.

Responsible epigenetics communication distinguishes between the scientifically well-supported finding (environmental experiences can alter gene expression in lasting, sometimes intergenerational ways) and the overclaimed version (acquired characteristics are generally inherited, Lamarckism vindicated).

Epigenetic dysregulation is a universal feature of cancer and is now recognized as a driver of malignancy alongside genetic mutation, not merely a consequence of it. Cancer genomes show two characteristic epigenetic abnormalities that operate simultaneously. The first is global DNA hypomethylation: a widespread, genome-wide reduction in methylation compared to normal tissues.

This hypomethylation occurs particularly in repetitive elements and gene bodies, and has several consequences including genomic instability (hypomethylated repetitive elements can move within the genome, causing mutations) and aberrant activation of genes that should be silenced.

The second is focal promoter hypermethylation: specific, targeted increases in methylation at the promoter regions of tumor suppressor genes, the genes that normally constrain cell proliferation and induce apoptosis (programmed cell death). Hypermethylation silences these genes, which provides a selective growth advantage to cancer cells analogous to a conventional tumor-suppressing mutation but without changing the DNA sequence.

This means that cancer cells can effectively ‘turn off’ tumor suppressor genes through epigenetic silencing rather than through mutation, and the resulting silencing can be heritable through cell division. The reversibility of epigenetic changes, unlike genetic mutations, they do not permanently alter the DNA sequence, has made the epigenome an attractive therapeutic target. Two classes of epigenetic drugs have been approved for clinical use.

DNA methyltransferase inhibitors (azacitidine, decitabine) prevent methylation, reactivating silenced tumor suppressor genes and disrupting cancer cell epigenetic patterns. Histone deacetylase inhibitors (vorinostat, romidepsin) alter chromatin structure in ways that promote cancer cell death.

Both drug classes are currently approved primarily for hematological malignancies, and research is ongoing into their application in solid tumors and in combination with other therapies.

ContributorsView this article on CitePep ↗

Emir BaycanCorrected

View correction ↗

When Notes Fly Editorial·Editorial standards·Updated September 27, 2026·4147 views

Want to write for us?

Pitch a guide to When Notes Fly

Evergreen subjects, primary sources, and a four-stage review. Contributors are chosen for knowledge of the specific topic.

Read the content guide →

Share this article

How Epigenetics Functions: Gene Regulation and Experience

Key Definitions

The Molecular Machinery: How Cells Turn Genes On and Off

X-Inactivation: A Textbook Example With a Real Mechanism

Genomic Imprinting: When Parental Origin Matters

Environmental Influence on Gene Expression: What the Evidence Actually Supports

Transgenerational Inheritance: What Is Solid and What Is Overstated

Epigenetics in Medicine: Cancer and Beyond

What Epigenetics Does Not Mean

Sources & Further Reading

Further Reading

Frequently asked questions

Noticed an error on this page?

How Epigenetics Functions: Gene Regulation and Experience

Key Definitions

The Molecular Machinery: How Cells Turn Genes On and Off

X-Inactivation: A Textbook Example With a Real Mechanism

Genomic Imprinting: When Parental Origin Matters

Environmental Influence on Gene Expression: What the Evidence Actually Supports

Transgenerational Inheritance: What Is Solid and What Is Overstated

Epigenetics in Medicine: Cancer and Beyond

What Epigenetics Does Not Mean

Related Articles

Sources & Further Reading

Further Reading

Frequently asked questions

Noticed an error on this page?

Continue reading

One guide a week, sourced